Peer Review History

Original SubmissionJuly 29, 2020
Decision Letter - Jamie Males, Editor

PONE-D-20-23688Global epidemiology of aerophagia in children and adolescents: A systematic review and meta-analysisPLOS ONE

Dear Dr. Rajindrajith,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Two reviewers have evaluated your manuscript and identified several aspects that need clarification and revision in order to meet PLOS ONE's publication criteria. Please pay particular attention to Reviewer 1's concerns and queries regarding your study design and search criteria.

Please submit your revised manuscript by Jan 13 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Jamie Males

Staff Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that Figure 3 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 3 to publish the content specifically under the CC BY 4.0 license.  

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

3. In the methods, please describe how to provide the results of the publication bias analysisi in the figures and state the specific test (Begg's or Egger's) used in the Methods section. Please also state the cut-off used to indicate heterogeneity using the I2 statistic in the Methods section.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: I Don't Know

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript is based on a systematic review and meta analysis of studies reporting aerophagia in children and adolescents. The systematic review appears to have been well conducted. I have a major concern regarding the manuscript and I have found several minor inaccuracies.

Major concern -

it is not appropriate to undertake a systematic review and meta analysis of the studies reporting the prevalence of aerophagia and to include data on risk factors and consequences. Studies on prevalence need samples representative of a defined population but representativeness is not an essential requirement to look at risk factors or consequences. It is likely that there is more literature reporting data on risk factors and consequences but these would not have met the inclusion criteria used in this review. In the manuscript there had been no synthesis of data related to the risk factors for aerophagia or its influence on the lives of children. Suggest confining the manuscript to the prevalence of aerophagia

Minor issues -

1. I think "Global epidemiology" is rather misleading in the title for a review of the prevalence of a condition.

2. Israel, Jordan, and Lebanon are listed under Europe in Table 1 but all three are in Asia.

3. Reference number 27 is stated as the source of some of the data in Table 1, but this data has been extracted from reference number 16.

4. Line 187 "There are five studies from four Asian countries[1-3, 13-15]' ...". This not correct.

There are six references (1, 2, 3, 13, 14, & 15) and in Table 1 under Asia six studies from four countries have been listed.

5. Line 196 in the manuscript mentions 14 studies but Table 2 has 19 studies.

6. How was the data for figure 3 obtained? Is figure 3 really necessary?

Reviewer #2: Although aerophagia in children is clinically less important comparing to other medical conditions, underlying pathophysiology can be important and needs further investigation. This study describes prevalence of aerophagia in children across the world, and discuss its effects on their life and possible underlying causes, such as stress and maltreatments. This study sends a message that aerophagia in children might have underlying causes and it should be investigated accordingly to prevent children from unnecessary stress and/or maltreatments.

I would suggest a further research to assess super-gastric belching in children. Because supra-gastric belching in children has not been well documented yet, and it can also be related to stress factors.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Arunasalam Pathmeswaran

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Answers to Editorial and Reviewer Comments

Editorial Comments

Comment

Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response

All are in accordance with PLOS ONE’s style requirements

Comment

We note that Figure 3 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

Response

This figure was generated by the authors using the software ArcGIS 10.2 (Esri, Redlands, Canada). We used ESRI base map/base map outline. We have access to this software as it is a free access software. Therefore, our figures are original and do not need to obtain copyright permission from other authors, journals, or authorities. The caption of the figure 3 was updated according to the ESRI guidelines as well.

Comment

In the methods, please describe how to provide the results of the publication bias analysis in the figures and state the specific test (Begg's or Egger's) used in the Methods section. Please also state the cut-off used to indicate heterogeneity using the I2 statistic in the Methods section.

Response

The necessary details were included in the method section as suggested by the editor.

Comment

In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Response

This is a systematic review and a meta-analysis. All the data included in this study are available in the public domain as published full text articles.

Comment

Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information.

Response

Included at the end of the manuscript.

Reviewer 1

This manuscript is based on a systematic review and meta analysis of studies reporting aerophagia in children and adolescents. The systematic review appears to have been well conducted. I have a major concern regarding the manuscript and I have found several minor inaccuracies.

Comment

it is not appropriate to undertake a systematic review and meta analysis of the studies reporting the prevalence of aerophagia and to include data on risk factors and consequences. Studies on prevalence need samples representative of a defined population but representativeness is not an essential requirement to look at risk factors or consequences. It is likely that there is more literature reporting data on risk factors and consequences but these would not have met the inclusion criteria used in this review. In the manuscript there had been no synthesis of data related to the risk factors for aerophagia or its influence on the lives of children. Suggest confining the manuscript to the prevalence of aerophagia.

Response

Agreeing with the reviewer, we removed the data on risk factor and limited our manuscript to prevalence of aerophagia

Comment

I think "Global epidemiology" is rather misleading in the title for a review of the prevalence of a condition.

Response

We changed the title according to the reviewer comment.

Comment

Israel, Jordan, and Lebanon are listed under Europe in Table 1 but all three are in Asia.

Response

We thank the reviewer for pointing out this issue. It was corrected and Israel, Jordan, and Lebanon were included into Asian studies.

Comment

Reference number 27 is stated as the source of some of the data in Table 1, but this data has been extracted from reference number 16.

Response

We thank the reviewer for pointing out this error. The data were extracted from reference 16. The error was corrected.

Comment

Line 187 "There are five studies from four Asian countries[1-3, 13-15]' ...". This not correct.

Response

The studies were rearranged, and this error was corrected as pointed out by the reviewer.

Comment

There are six references (1, 2, 3, 13, 14, & 15) and in Table 1 under Asia six studies from four countries have been listed.

Response

This is correct. Three studies from Sri Lanka. The other countries were Iran, India, and Japan. Now we have added Jordan, Israel, and Lebanon to this list as suggested by the reviewer in his previous comment.

Comment

Line 196 in the manuscript mentions 14 studies but Table 2 has 19 studies.

Response

We thank the reviewer for pointing out this error. It was corrected to 19.

Comment

How was the data for figure 3 obtained? Is figure 3 really necessary?

Response

Each country had at least one prevalence rate for aerophagia. When there were more than one study providing prevalence, we calculated the average for the country through the meta-analysis. This was done for Sri Lanka and Colombia where we observed multiple prevalence rates. We believe that the prevalence map is necessary and if the reviewer is not disagreeing, we would like to keep it in the manuscript.

Reviewer 2

Comment

Although aerophagia in children is clinically less important comparing to other medical conditions, underlying pathophysiology can be important and needs further investigation. This study describes prevalence of aerophagia in children across the world, and discuss its effects on their life and possible underlying causes, such as stress and maltreatments. This study sends a message that aerophagia in children might have underlying causes and it should be investigated accordingly to prevent children from unnecessary stress and/or maltreatments.

Response

Thank you for your comment

Comment

I would suggest further research to assess super-gastric belching in children. Because supra-gastric belching in children has not been well documented yet, and it can also be related to stress factors.

Response

We have discussed the possibility of supra-gastric belching as an aetiological factor in the discussion stressing that it need to be looked at during evaluation.

Attachments
Attachment
Submitted filename: Reviewer comments and answers.docx
Decision Letter - Hugh Cowley, Editor

Epidemiology of aerophagia in children and adolescents: A systematic review and meta-analysis

PONE-D-20-23688R1

Dear Dr. Rajindrajith,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Hugh Cowley

Staff Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: Much improved by responding other reviewer's comments.

As I made comments on the previous occasion, this manuscript sends a message that aerophagia in children might have underlying clinical/psychological causes and it should be investigated accordingly. I would suggest a further study to assess supra-gastric belching in children.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Formally Accepted
Acceptance Letter - Hugh Cowley, Editor

PONE-D-20-23688R1

Epidemiology of aerophagia in children and adolescents: A systematic review and meta-analysis

Dear Dr. Rajindrajith:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Mr Hugh Cowley

Staff Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .